Renovaro Biosciences Inc. Gains 40.43%

Thu, May 23, 2024 at 07:39 PM

Renovaro Biosciences Inc. (RENB:NASDAQ) shot up at $1.32, a gain of 40.4%. On Thu, May 23, 2024, RENB:NASDAQ hit a New 2-Week High of $1.32. The stock got featured on our News Catalysts scanner on Thu, May 16, 2024 at 10:52 AM in the 'EARNINGS' category. From Thu, May 09, 2024, the stock recorded 30.00% Up Days and 18.18% Green Days

About Renovaro Biosciences Inc. (RENB:NASDAQ)

Enochian BioSciences Inc is a biopharmaceutical company. It is engaged in identifying, developing, manufacturing, and commercializing gene therapies.

Top 10 Gainers:

OneMedNet Corp. (ONMD:NASDAQ), 208.43%
Schmitt Industries, Inc. (SMIT:NASDAQ), 117.65%
Scopus BioPharma Inc. (SCPS:NASDAQ), 90.91%
Binah Capital Group Inc. (BCG:NASDAQ), 78.01%
Pineapple Holdings Inc Com (PEGY:NASDAQ), 61.44%
SRIVARU Holding Limited (SVMH:NASDAQ), 52.65%
Kubient Inc. (KBNT:NASDAQ), 50%
Renovaro Biosciences Inc. (RENB:NASDAQ), 40.43%
Latch Inc. (LTCH:NASDAQ), 32.56%
BeyondSpring Inc. (BYSI:NASDAQ), 25.18%